Jpmorgan Chase & Co »

Acadia Pharmaceuticals, Inc. cmn shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Acadia Pharmaceuticals, Inc. cmn shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Acadia Pharmaceuticals, Inc. cmn

Tip: Access up to 7 years of quarterly data

All positions including Acadia Pharmaceuticals, Inc. cmn held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acadia Pharmaceuticals, Inc. cmn by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-09-30 $415k 27k 15.38
2024-06-30 $439k 27k 16.25
2024-03-31 $1.8M 100k 18.49
2019-12-31 $1.3M 29k 42.79
2018-12-31 $323k 20k 16.15
2018-09-30 $1.8M 85k 20.76
2016-03-31 $6.0M 216k 27.96

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Nvidia Corporation Common (NVDA)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf Ser 1 S&p Common (SPY)
Meta Platforms Common (META)
Eli Lilly & Co Common (LLY)
Alphabet Common (GOOG)
Unitedhealth Group Common (UNH)
Mastercard Incorporated Common (MA)
Vanguard Index Fds S&p 500 Etf Common (VOO)
Ishares Core S&p 500 Etf Fund (IVV)
Vanguard Total Intl Bond Etf Fund (BNDX)
Broadcom Common (AVGO)
Exxon Mobil Corp Common (XOM)

View all positions for Jpmorgan Chase & Co

Top funds holding Acadia Pharmaceuticals, Inc. cmn

Group One Trading
Jpmorgan Chase & Co
Simplex Trading

View all funds holding Acadia Pharmaceuticals, Inc. cmn